$3.64
0.144%
Last update: Nov 4, 10:06 AM
Ironwood Pharmaceuticals Inc
IRWDNASDAQ
The average analyst price target for Ironwood Pharmaceuticals is $8.46, 132.4% above the current price. Of 6 analysts, 4 rate it Buy and 2 Hold. Targets range from $0.70 to $21. The latest change came on Feb 26, 2026, when Citizens raised its price target on Ironwood Pharmaceuticals from $8 to $10 and kept a Market Outperform rating.
Price Target Range — 8 Quarters
Analyst Consensus — 6 Analysts
Rating Trend — Last 9 Months
